Metoprololo Doc Generici

Metoprolol Tartrate, the active ingredient in Metoprololo Doc Generici, is a beta blocker presented as a tablet for oral use. It lowers blood pressure and heart rate and is used in adults with cardiovascular conditions such as hypertension and angina. GNH USA supplies Metoprololo Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprololo Doc Generici is a selective β1‑adrenergic blocker that acts on the cardiovascular system to control pressure and rhythm. - Hypertension: reduces systolic and diastolic pressure to lower risk of stroke and heart attack. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Post‑myocardial infarction: limits adverse remodeling and improves survival after a heart attack. - Heart failure: improves ventricular function and reduces hospitalisation rates. - Cardiac arrhythmias: stabilises heart rhythm by slowing conduction through the AV node.

Metoprololo Doc Generici may cause a range of adverse reactions.

Common Side Effects: - Fatigue or tiredness - Dizziness, especially when standing quickly - Cold extremities such as hands or feet - Gastrointestinal upset, including nausea or abdominal discomfort - Mild depression or mood changes - Reduced exercise tolerance

Serious or Rare Side Effects: - Severe bradycardia (abnormally low heart rate) - Hypotension leading to fainting or shock - Acute heart failure exacerbation - Bronchospasm in patients with asthma or COPD - Allergic reactions such as rash, itching, or angioedema - Cardiac conduction disturbances (e.g., AV block).

Before initiating therapy, clinicians should assess patient history and comorbidities. - Cardiovascular assessment: evaluate heart rate, blood pressure, and cardiac function. - Respiratory status: avoid use in uncontrolled asthma or severe COPD. - Diabetes monitoring: watch for masking of hypoglycaemia symptoms. - Renal or hepatic impairment: consider dose adjustment or close monitoring. - Drug discontinuation: taper gradually to prevent rebound tachycardia or hypertension. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Metoprololo Doc Generici can alter the effects of several concomitant medicines.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): risk of severe AV block. - Class IA anti‑arrhythmics (quinidine, procainamide): increased risk of conduction disorders.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: possible masking of hypoglycaemia signs. - NSAIDs: may blunt antihypertensive effect. - Antidepressants (SSRIs, SNRIs): potential for increased bradycardia. - Inhaled bronchodilators: may reduce bronchodilator efficacy in asthmatic patients.